Subramanian, S., M. Rajendiran, M. Paramasivam, I. Murugesan, S. Palani, and S. Velusamy. “Advances in SGLT2 Inhibitor Therapy: Comparative Evidence for Empagliflozin and Dapagliflozin in Cardio-Renal-Metabolic Disorders”. International Journal of Advancement in Life Sciences Research, Vol. 9, no. 4, Oct. 2026, pp. 56-68, doi:https://doi.org/10.31632/ijalsr.2026.v09i04.004.